mtor total (Cell Signaling Technology Inc)
Structured Review

Mtor Total, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 8593 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/total+mtor/mTOR+Antibody/pmc12975357-114-49-54
Average 97 stars, based on 8593 article reviews
Images
1) Product Images from "Amino Acid Signaling in Skeletal Muscle Is Blunted by Prematurity in a Piglet Model"
Article Title: Amino Acid Signaling in Skeletal Muscle Is Blunted by Prematurity in a Piglet Model
Journal: The Journal of Nutrition
doi: 10.1016/j.tjnut.2025.101303
Figure Legend Snippet: Current concepts of multiple amino acid–sensing input to mTORC1. AA, amino acid; Akt, RAC-α serine/threonine-protein kinase; ARF1, ADP-ribosylation factor 1; BCAA, branched-chain amino acid; CASTOR1, cytosolic arginine sensor for mTORC1 subunit 1; GATOR1/2, GAP activity toward RAGs 1/2; LARS, leucine-tRNA-synthase; LAT1/SLC7A5, L-type amino acid transporter 1; mTORC1, mechanistic target of rapamycin complex 1; PI3K, phosphatidylinositol-3-kinase; RAB1A, Ras-related protein Rab-1A; Rag A/B C/D, RAS-related GTP-binding protein A/B C/D; Ragulator, Late endosomal/lysosomal adaptor and MAPK and mTOR activator; Rheb, Ras homolog enriched in brain; SAM, S-adenosyl methionine; SAMTOR, S-adenosylmethionine sensor upstream of mTORC1; SAR1B, secretion-associated Ras-related GTPase 1B; Sestrin1/2, stress response protein 1/2; SLC38A9, solute carrier family 38 member 9; SNAT2, sodium-coupled neutral amino acid transporter 2; TARS2, threonyl-tRNA synthetase 2; TFEB, transcription factor EB; TSC1/2, tuberous sclerosis complex 1/2; V-ATPase, vacuolar H + -ATPase. Created in BioRender. Ramos dos Santos, A.C. (2026) https://BioRender.com/54b947z .
Techniques Used: Activity Assay, Binding Assay
Related Articles
Incubation:Article Title: Non-redundant functions of insulin/FOXO and EcR signaling pathways regulate accessory gland structure, function and male fertility in Drosophila. Article Snippet: This is a PDF of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability.. This version will undergo additional copyediting, typesetting and review before it is published in its final form.. As such, this version is no longer the Accepted Manuscript, but it is not yet the definitive Version of Record; we are providing this early version to give early visibility of the article. Article Title: Targeting FOXA1 with repurposed tigecycline to overcome therapeutic resistance in castration-resistant prostate cancer Article Snippet: .. After blocking with 5% non-fat milk in PBS 159 for 1 h at room temperature, the membranes were incubated overnight at 4 °C with the 160 following primary antibodies: FOXA1 (Abcam, #ab23738, 1:1000); GAPDH 161 (Proteintech, # 60004-1-Ig, 1:10000); CCNA2 (Zenbio, #R27473, 1:500); UBE2C 162 (Zenbio, #R27398, 1:500); CDK1 (Proteintech, #19532-1-AP, 1:2000); PSA (Santa 163 Cruz, #sc-7316, 1:200); AR (Proteintech, #22089-1-AP, 1:5000); β-Actin (Proteintech, 164 #20536-1-AP, 1:5000); NKX3.1 (Zenbio, #R382345, 1:1000); flag (Proteintech, 165 #66008-4-Ig, 1:5000); FOXA1 (CST, #53528, 1:1000); ERK2 (Zenbio, #R22846, 166 1:1000); Phospho-AKT1 (Zenbio, #310021, 1:1000); Phospho-S6 (CST, #4858, 167 1:2000); S6 (CST, #2217, 1:1000); H3 (CST, #9715, 1:1000); 4EBP1 (CST, #9644, 168 1:1000); Phospho-4EBP1 (CST, #2855, 1:1000); Article Title: Metformin (DMBG) ameliorates diabetic erectile dysfunction via the AMPK/mTOR pathway in association with endothelial autophagy reactivation. Article Snippet: Background: Diabetes mellitus erectile dysfunction (DMED) is a prevalent complication with limited treatment efficacy.. Metformin (dimethylbiguanide, DMBG) shows therapeutic potential, but its underlying mechanisms remain unclear.. This study investigated whether DMBG alleviates DMED in association with restored endothelial Article Title: Madecassic acid attenuates sepsis-associated acute lung injury by regulating the PI3K/AKT/mTOR pathway to mediate anti-inflammatory, antioxidant and anti-apoptotic effects Article Snippet: .. The membranes were then incubated with the corresponding primary antibodies: Bax (2772, CST), Bcl2 (3498, CST), cleaved caspase-3 (9661, CST), p-PI3K (4228, CST), PI3K (4292, CST), p-AKT (4060, CST), AKT (9272, CST), Blocking Assay:Article Title: Targeting FOXA1 with repurposed tigecycline to overcome therapeutic resistance in castration-resistant prostate cancer Article Snippet: .. After blocking with 5% non-fat milk in PBS 159 for 1 h at room temperature, the membranes were incubated overnight at 4 °C with the 160 following primary antibodies: FOXA1 (Abcam, #ab23738, 1:1000); GAPDH 161 (Proteintech, # 60004-1-Ig, 1:10000); CCNA2 (Zenbio, #R27473, 1:500); UBE2C 162 (Zenbio, #R27398, 1:500); CDK1 (Proteintech, #19532-1-AP, 1:2000); PSA (Santa 163 Cruz, #sc-7316, 1:200); AR (Proteintech, #22089-1-AP, 1:5000); β-Actin (Proteintech, 164 #20536-1-AP, 1:5000); NKX3.1 (Zenbio, #R382345, 1:1000); flag (Proteintech, 165 #66008-4-Ig, 1:5000); FOXA1 (CST, #53528, 1:1000); ERK2 (Zenbio, #R22846, 166 1:1000); Phospho-AKT1 (Zenbio, #310021, 1:1000); Phospho-S6 (CST, #4858, 167 1:2000); S6 (CST, #2217, 1:1000); H3 (CST, #9715, 1:1000); 4EBP1 (CST, #9644, 168 1:1000); Phospho-4EBP1 (CST, #2855, 1:1000); Article Title: Metformin (DMBG) ameliorates diabetic erectile dysfunction via the AMPK/mTOR pathway in association with endothelial autophagy reactivation. Article Snippet: Background: Diabetes mellitus erectile dysfunction (DMED) is a prevalent complication with limited treatment efficacy.. Metformin (dimethylbiguanide, DMBG) shows therapeutic potential, but its underlying mechanisms remain unclear.. This study investigated whether DMBG alleviates DMED in association with restored endothelial |
